These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38899842)

  • 1. Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison.
    Charalel RA; Mushlin AI; Zheng X; Mao J; Carlos RC; Brown RS; Ibrahim S; Fortune BE; Talenfeld AD; Madoff DC; Johnson MS; Sedrakyan A
    AJR Am J Roentgenol; 2024 Aug; 223(2):e2431272. PubMed ID: 38899842
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
    Shaya FT; Breunig IM; Seal B; Mullins CD; Chirikov VV; Hanna N
    Pharmacoeconomics; 2014 Jan; 32(1):63-74. PubMed ID: 24293197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.
    Skill NJ; Butler J; O'Brien DC; Kays JK; Kubal CA; Liangpunsakul S; Ninad N; Maluccio MA
    Transplant Proc; 2019; 51(6):1907-1912. PubMed ID: 31399174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
    Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
    Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
    Landman MP; Feurer ID; Pinson CW; Moore DE
    HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
    Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
    J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care costs associated with hepatocellular carcinoma: a population-based study.
    Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
    Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
    Mironov O; Jaberi A; Kachura JR
    J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
    Tsilimigras DI; Hyer JM; Diaz A; Moris D; Abbas A; Dillhoff M; Cloyd JM; Ejaz A; Beane JD; Tsung A; Pawlik TM
    Am J Surg; 2021 Sep; 222(3):570-576. PubMed ID: 33485619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.
    Huo J; Aloia TA; Xu Y; Chung TH; Sheu T; Tina Shih YC
    Value Health; 2019 Mar; 22(3):284-292. PubMed ID: 30832966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Survival After Surgery Versus Ablation for Early Liver Cancer in a Large, Nationally Representative Cohort.
    Charalel RA; Mushlin AI; Li D; Mao J; Ibrahim S; Carlos RC; Kwan SW; Fortune B; Talenfeld AD; Brown RS; Madoff DC; Johnson MS; Sedrakyan A
    J Am Coll Radiol; 2022 Nov; 19(11):1213-1223. PubMed ID: 36208842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
    Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
    Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
    Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
    J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.